The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19

Detalhes bibliográficos
Autor(a) principal: Pereira, Marcos
Data de Publicação: 2020
Outros Autores: Paixão, Enny, Trajman, Anete, Souza, Ramon Andrade de, Natividade, Marcio Santos da, Pescarini, Julia M., Pereira, Susan Martins, Barreto, Florisneide Rodrigues, Ximenes, Ricardo, Dalcomo, Margareth, Ichihara, Maria Yury, Nunes, Ceuci, Barral Netto, Manoel, Barreto, Maurício Lima
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/42238
Resumo: Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.
id CRUZ_0cfc874e7b484a31691c4b79e2a8f6cd
oai_identifier_str oai:www.arca.fiocruz.br:icict/42238
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Pereira, MarcosPaixão, EnnyTrajman, AneteSouza, Ramon Andrade deNatividade, Marcio Santos daPescarini, Julia M.Pereira, Susan MartinsBarreto, Florisneide RodriguesXimenes, RicardoDalcomo, MargarethIchihara, Maria YuryNunes, CeuciBarral Netto, ManoelBarreto, Maurício Lima2020-07-14T11:07:17Z2020-07-14T11:07:17Z2020PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020.1465-9921https://www.arca.fiocruz.br/handle/icict/4223810.1186/s12931-020-01439-4engBMCCOVID-19Vacina BCGSindrome respiratória agudaCoronavirusSARS-CoV-2Bacillus Calmette GuerinMortalidadeCOVID-19BCG VaccineAcute Respiratory SyndromeCoronavirusSARS-CoV-2Bacillus Calmette GuerinMortalityThe need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleFederal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil / London School of Hygiene and Tropical Medicine. Faculty of Epidemiology London, UK.Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Rio de Janeiro, RJ, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.Universidade Federal de Pernambuco. Departamento de Medicina Tropical. Recife, PE, Brasil.Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Centro de Referência Hélio Fraga. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Secretaria Estadual de Saúde da Bahia. Hospital Couto Maia. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Medicina. Salvador, BA, Brasil.Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil / Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Centro de Integração de Dados e Conhecimento para Saúde. Salvador, BA, Brasil.Bacillus Calmette-Guérin (BCG) vaccination is routine and near-universal in many low- and middle-income countries (LMIC). It has been suggested that BCG can have a protective effect on COVID-19 morbidity and mortality. This commentary discusses the limitations of the evidence around BCG and COVID-19. We argue that higher-quality evidence is necessary to understand the protective effect of the BCG vaccine from existing, secondary data, while we await results from clinical trials currently conducted in different settings.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/42238/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALPereira_Marcos_etal_IGM_2020_COVID-19.pdfPereira_Marcos_etal_IGM_2020_COVID-19.pdfapplication/pdf468005https://www.arca.fiocruz.br/bitstream/icict/42238/2/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf753fe47d85956019a0190b3034dea079MD52TEXTPereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtPereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtExtracted texttext/plain13768https://www.arca.fiocruz.br/bitstream/icict/42238/3/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf.txtfd13df59e511f584c806f86208751370MD53icict/422382023-03-15 14:34:23.466oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:23Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
title The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
spellingShingle The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
Pereira, Marcos
COVID-19
Vacina BCG
Sindrome respiratória aguda
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortalidade
COVID-19
BCG Vaccine
Acute Respiratory Syndrome
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortality
title_short The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
title_full The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
title_fullStr The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
title_full_unstemmed The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
title_sort The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19
author Pereira, Marcos
author_facet Pereira, Marcos
Paixão, Enny
Trajman, Anete
Souza, Ramon Andrade de
Natividade, Marcio Santos da
Pescarini, Julia M.
Pereira, Susan Martins
Barreto, Florisneide Rodrigues
Ximenes, Ricardo
Dalcomo, Margareth
Ichihara, Maria Yury
Nunes, Ceuci
Barral Netto, Manoel
Barreto, Maurício Lima
author_role author
author2 Paixão, Enny
Trajman, Anete
Souza, Ramon Andrade de
Natividade, Marcio Santos da
Pescarini, Julia M.
Pereira, Susan Martins
Barreto, Florisneide Rodrigues
Ximenes, Ricardo
Dalcomo, Margareth
Ichihara, Maria Yury
Nunes, Ceuci
Barral Netto, Manoel
Barreto, Maurício Lima
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pereira, Marcos
Paixão, Enny
Trajman, Anete
Souza, Ramon Andrade de
Natividade, Marcio Santos da
Pescarini, Julia M.
Pereira, Susan Martins
Barreto, Florisneide Rodrigues
Ximenes, Ricardo
Dalcomo, Margareth
Ichihara, Maria Yury
Nunes, Ceuci
Barral Netto, Manoel
Barreto, Maurício Lima
dc.subject.other.pt_BR.fl_str_mv COVID-19
Vacina BCG
Sindrome respiratória aguda
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortalidade
topic COVID-19
Vacina BCG
Sindrome respiratória aguda
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortalidade
COVID-19
BCG Vaccine
Acute Respiratory Syndrome
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortality
dc.subject.en.pt_BR.fl_str_mv COVID-19
BCG Vaccine
Acute Respiratory Syndrome
Coronavirus
SARS-CoV-2
Bacillus Calmette Guerin
Mortality
description Federal University of Bahia. Institute of Collective Health. Salvador, BA, Brazil.
publishDate 2020
dc.date.accessioned.fl_str_mv 2020-07-14T11:07:17Z
dc.date.available.fl_str_mv 2020-07-14T11:07:17Z
dc.date.issued.fl_str_mv 2020
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/42238
dc.identifier.issn.pt_BR.fl_str_mv 1465-9921
dc.identifier.doi.none.fl_str_mv 10.1186/s12931-020-01439-4
identifier_str_mv PEREIRA, Marcos et al. The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19. Respiratory Research, v. 21, p. 1-3, 2020.
1465-9921
10.1186/s12931-020-01439-4
url https://www.arca.fiocruz.br/handle/icict/42238
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv BMC
publisher.none.fl_str_mv BMC
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/42238/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/42238/2/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf
https://www.arca.fiocruz.br/bitstream/icict/42238/3/Pereira_Marcos_etal_IGM_2020_COVID-19.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
753fe47d85956019a0190b3034dea079
fd13df59e511f584c806f86208751370
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009122234204160